Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Copeland

Showing results (511-520 of 573) with videos related to

Pageof 58
Sort By:
Molecular Cancer Therapeutics|August 25, 2017
EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCLDorothy Brach, Danielle Johnston-Blackwell, Allison Drew, et al.
Plos One|July 9, 2016
Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Journal of Medicinal Chemistry|January 16, 2016
The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of TazemetostatKevin W Kuntz, John E Campbell, Heike Keilhack, et al.
Chemical Biology & Drug Design|September 18, 2012
Conformational adaptation drives potent, selective and durable inhibition of the human protein methyltransferase DOT1LAravind Basavapathruni, Lei Jin, Scott R Daigle, et al.
Plos One|January 14, 2017
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Journal of the American College of Surgeons|January 16, 2017
Hospital Readmissions after Surgery: How Important Are Hospital and Specialty Factors?Robert H Hollis, Laura A Graham, Joshua S Richman, et al.
Nature|June 11, 2015
Supramolecular assemblies underpin turnover of outer membrane proteins in bacteriaPatrice Rassam, Nikki A Copeland, Oliver Birkholz, et al.
The Journal of Biological Chemistry|July 11, 1998
Identification of a novel inhibitor of mitogen-activated protein kinase kinaseM F Favata, K Y Horiuchi, E J Manos, et al.
Plos One|December 11, 2014
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin LymphomasSarah K Knutson, Natalie M Warholic, L Danielle Johnston, et al.
Journal of Bacteriology|May 19, 2006
The genome of the obligately intracellular bacterium Ehrlichia canis reveals themes of complex membrane structure and immune evasion strategiesK Mavromatis, C Kuyler Doyle, A Lykidis, et al.
Pageof 58

Showing results (511-520 of 573) with videos related to

Sort By:
Pageof 58
Molecular Cancer Therapeutics|August 25, 2017
EZH2 Inhibition by Tazemetostat Results in Altered Dependency on B-cell Activation Signaling in DLBCLDorothy Brach, Danielle Johnston-Blackwell, Allison Drew, et al.
Plos One|July 9, 2016
Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Journal of Medicinal Chemistry|January 16, 2016
The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of TazemetostatKevin W Kuntz, John E Campbell, Heike Keilhack, et al.
Chemical Biology & Drug Design|September 18, 2012
Conformational adaptation drives potent, selective and durable inhibition of the human protein methyltransferase DOT1LAravind Basavapathruni, Lei Jin, Scott R Daigle, et al.
Plos One|January 14, 2017
Correction: Preclinical Evidence of Anti-Tumor Activity Induced by EZH2 Inhibition in Human Models of Synovial SarcomaSatoshi Kawano, Alexandra R Grassian, Masumi Tsuda, et al.
Journal of the American College of Surgeons|January 16, 2017
Hospital Readmissions after Surgery: How Important Are Hospital and Specialty Factors?Robert H Hollis, Laura A Graham, Joshua S Richman, et al.
Nature|June 11, 2015
Supramolecular assemblies underpin turnover of outer membrane proteins in bacteriaPatrice Rassam, Nikki A Copeland, Oliver Birkholz, et al.
The Journal of Biological Chemistry|July 11, 1998
Identification of a novel inhibitor of mitogen-activated protein kinase kinaseM F Favata, K Y Horiuchi, E J Manos, et al.
Plos One|December 11, 2014
Synergistic Anti-Tumor Activity of EZH2 Inhibitors and Glucocorticoid Receptor Agonists in Models of Germinal Center Non-Hodgkin LymphomasSarah K Knutson, Natalie M Warholic, L Danielle Johnston, et al.
Journal of Bacteriology|May 19, 2006
The genome of the obligately intracellular bacterium Ehrlichia canis reveals themes of complex membrane structure and immune evasion strategiesK Mavromatis, C Kuyler Doyle, A Lykidis, et al.
Pageof 58